Murine AML cells carrying the MLL-AF9 oncofusion were generated via retroviral transduction of murine c-Kit positive HPCs, injected into syngeneic mice, and recovered from the bone marrow of these mice after the development of AML [38]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.